Millipore Sigma Vibrant Logo

HCYP4MAG-64K MILLIPLEX MAP Human Cytokine/Chemokine Magnetic Bead Panel IV

View Products on Sigmaaldrich.com
HCYP4MAG-64K

Special Offers

Design And Price Your Kit

Overview

Replacement Information

Special Offers

This panel is available for custom premix. Talk to your Protein Specialist today!

Key Spec Table

Analytes AvailableSpecies ReactivityKey ApplicationsMultiplexing Ordering RequirementsDetection Methods
BAFF/Blys BRAK/CXCL14 CCL28 CXCL16 HCC-4/CCL16 HMGB1 IFNβ IL-14 IL-19 IL-24 IL-28B IL-32α IL-34 IL-35 IL-36β/IL-1F8 IL-37/IL-1F7 IL-38/IL-1F10 MIP-4 MPIF-1/CCL23 YKL40 HMplexPlease note: Sample Type must be selected when configuring this kit. HMGB1 can be measured in serum and plasma samples only.Luminex xMAP
Description
Catalogue NumberHCYP4MAG-64K
Trade Name
  • MILLIPLEX
DescriptionMILLIPLEX MAP Human Cytokine/Chemokine Magnetic Bead Panel IV
OverviewEMD Millipore’s MILLIPLEX® MAP Cytokine/Chemokine Magnetic Bead Panel IV is a 20-plex kit to be used for the simultaneous quantification of any or all of the following analytes in serum, plasma or culture supernatant samples: BAFF/Blys, BRAK/CSCL14, CCL28, CXCL16, HMGB1, IFNβ, IL-14, IL-19, IL-24, IL-28B, IL-32α, IL-34, IL-35, IL-36β, IL-37, IL-38, MIP-4/PARC/CCL18, MPIF-1/CL23 and YKL40/CHI3L1.

MILLIPLEX® MAP offers the broadest selection of analytes across a wide range of disease states and species. Once the analytes of interest have been identified, you can rely on the quality that we build into each kit to produce results you can trust. In addition to the assay characteristics listed in the protocol, other performance criteria evaluated during the validation process include: cross-reactivity, dilution linearity, kit stability, and sample behavior (e.g. detectability and stability). Each panel and kit meets stringent manufacturing criteria to ensure batch-to-batch reproducibility.

Each MILLIPLEX® MAP panel and kit includes:
• Quality controls (QCs) provided to qualify assay performance

• Comparison of standard (calibrator) and QC lots to a reference lot to ensure lot-to-lot consistency

• Optimized serum matrix to mimic native analyte environment

• Detection antibody cocktails designed to yield consistent analyte profiles within panel


EMD Millipore’s MILLIPLEX® MAP Human Cytokine IV Magnetic Bead Panel is part of the most versatile system available for cytokine research. From our single to multiplex biomarker solutions, we partner with you to design, develop, analytically validate and build the most comprehensive library available for protein detection and quantitation.
Background InformationInflammation and immune cell response are key to maintaining homeostasis. The more we understand mechanisms of disease, the more we discover the role that inflammation plays in the etiology of disease: certainly immunological diseases, such as allergic reactions, asthma, infectious disease and an ever-growing number of conditions under the autoimmune umbrella, but also neurodegenerative disease, metabolic and cardiovascular disease and even cancer. The ability to measure multiple inflammation biomarkers simultaneously using EMD Millipore’s MILLIPLEX® MAP panels, based on the Luminex xMAP® technology, to establish disease profiles that can be used for screening, diagnosis and response to treatment is critical for understanding the pathogenesis of these diseases.
References
Product Information
Detection methodLuminex xMAP
ConfigurationDesign your multiplex kit by choosing available analytes within this panel.
Precision, %
  • Intra-assay: 10
  • Inter-assay:15-25
Multiplex Ordering RequirementsPlease note: Sample Type must be selected when configuring this kit. HMGB1 can be measured in serum and plasma samples only.
Panel TypeMAGNETIC Cytokines/Chemokines
Quality LevelMQ200
Applications
ApplicationThe Human Inflammation / Immunology Bead-Based Multiplex Cytokine/Chemokine Assay kit IV, using the Luminex xMAP technology, enables the simultaneous analysis of 20 cytokine and chemokine biomarkers in human serum, plasma and cell culture samples.
Key Applications
  • Multiplexing
Application Notes• This is an overnight or two-hour incubation assay; however, for best results an overnight incubation is recommended.

• A maximum of 25 μL per well of 1:4 diluted serum or plasma can be used. Tissue culture supernatant may require a dilution with an appropriate control medium prior to assay. Please note that HMGB1 can be measured in serum and plasma samples only.
Biological Information
SpecificityCross-reactivity between the antibodies and any of the other analytes in this panel is non-detectable or negligible.
Species Reactivity
  • Human
Analytes Available
  • BAFF/Blys
  • BRAK/CXCL14
  • CCL28
  • CXCL16
  • HCC-4/CCL16
  • HMGB1
  • IFNβ
  • IL-14
  • IL-19
  • IL-24
  • IL-28B
  • IL-32α
  • IL-34
  • IL-35
  • IL-36β/IL-1F8
  • IL-37/IL-1F7
  • IL-38/IL-1F10
  • MIP-4
  • MPIF-1/CCL23
  • YKL40
Cross ReactivityCross-reactivity between the antibodies and any of the other analytes in this panel is non-detectable or negligible.
Accuracy
  • BAFF/Blys: 101%
  • BRAK/CSCL14: 101%
  • CCL28: 91%
  • CXCL16: 103%
  • HCC-4/CCL16: 110%
  • HMGB1: 104%
  • IFNβ: 97%
  • IL-14: 104%
  • IL-19: 106%
  • IL-24: 99%
  • IL-28B: 101%
  • IL-32α: 89%
  • IL-34: 110%
  • IL-35: 95%
  • IL-36β: 98%
  • IL-37: 99%
  • IL-38: 104%
  • MIP-4/PARC/CCL18: 101%
  • MPIF-1/CL23: 102%
  • YKL40/CHI3L1: 100%
Physicochemical Information
Sensitivity
  • MPIF-1: 7.8 pg/mL
  • BRAK: 607 pg/mL
  • CXCL16: 4.7 pg/mL
  • HCC-4: 28.4 pg/mL
  • MIP-4/PARC: 6.6 pg/mL
  • IL-34: 121.5 pg/mL
  • IL-24: 0.8 ng/mL
  • IL-35: 0.8 ng/mL
  • IL-37/IL-1F7: 5.2 pg/mL
  • IL-19: 248.2 pg/mL
  • CCL28: 100.8 pg/mL
  • HMGB1/HMG1: 10.5 ng/mL
  • IFNβ: 375.6 pg/mL
  • IL-38: 33.2 pg/mL
  • IL-28B/IFN-λ3: 17.2 pg/mL
  • BAFF/BLyS: 0.9 ng/mL
  • IL-14/α-Taxilin: 27.7 pg/mL
  • IL-36β: 3.5pg/mL
  • IL-32α: 32.1 pg/mL
  • YKL40/CHI3L1: 0.30 ng/mL
Standard Curve Range
  • BAFF/Blys: 0.44-400 ng/mL
  • BRAK/CXCL14: 488-500,000 pg/mL
  • CCL28: 98-100,000 pg/mL
  • CXCL16: 3-3,000 pg/mL
  • HMGB1: 2.0-2,000 ng/mL
  • IFNβ: 488 – 500,000 pg/mL
  • IL-14: 24-25,000 pg/mL
  • IL-19: 244-250,000 pg/mL
  • IL-24: 0.7-750 ng/mL
  • IL-28B: 29-30,000 pg/mL
  • IL-32α: 39-40,000 pg/mL
  • IL-34: 98-100,000 pg/mL
  • IL-35: 0.8-800 ng/mL
  • IL-36β: 2- 2,000 pg/mL
  • IL-37: 5 – 5,000 pg/mL
  • IL-38: 49-50,000 pg/mL
  • MIP-4/PARC/CCL18: 5-5,000 pg/mL
  • MPIF-1/CL23: 10-10,000 pg/mL
  • YKL40/CHI3L1: 0.1-100 ng/mL
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsRecommended storage for kit components is 2 - 8°C.
Packaging Information
Material Size96-well plate
Material Package96 well plate
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
HCYP4MAG-64K 04055977350173

Related Products & Applications

Related Products

Categories

Life Science Research > Antibodies and Assays > Immunoassays > Multiplexed Immunoassays > Milliplex MAP Assay Products > Configurable Kits
Life Science Research > Protein Detection and Quantification > Immunoassays > Multiplexed Immunoassays > Milliplex MAP Assay Products > Configurable Kits